Sign in
bf/NASDAQ:COYA_icon.jpeg

NASDAQ:COYA

Coya Therapeutics, Inc.

  • Stock

USD

Last Close

5.90

30/08 20:00

Market Cap

102.29M

Beta: -

Volume Today

4.79K

Avg: 49.57K

PE Ratio

−4.94

PFCF: −5.88

OverviewAnalysisFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
652.34K
-
1.34M
104.86%
1.49M
11.15%
average receivables
500
-
book value per share
0.55
-
-3.24
687.25%
3.51
208.20%
capex per share
-0.02
-
capex to depreciation
-8.48
-
capex to operating cash flow
0.04
-
capex to revenue
cash per share
0.66
-
2.29
248.53%
3.21
40.13%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
1.54
-
debt to equity
-1.54
-
dividend yield
earnings yield
-0.16
-
-1.20
641.02%
-0.11
91.13%
enterprise value
-8.72M
-
25.84M
396.26%
19.30M
25.28%
42.69M
121.13%
enterprise value over ebitda
-5.30
-
-1.97
62.77%
-5.40
173.76%
ev to operating cash flow
-6.62
-
-2.67
59.71%
-3.82
43.07%
ev to sales
7.11
-
free cash flow per share
-0.61
-
-2.79
356.81%
-1.10
60.61%
free cash flow yield
-0.13
-
-0.59
340.60%
-0.15
74.82%
graham net net
0.48
-
-4.19
967.02%
2.66
163.39%
graham number
3.03
-
20.33
571.69%
7.87
61.26%
income quality
0.80
-
0.59
25.91%
1.40
136.92%
intangibles to total assets
0
-
0
0
0
interest coverage
-4.03
-
interest debt per share
5.94
-
inventory turnover
invested capital
-1.54
-
market cap
30.18M
-
12.27M
59.33%
75.31M
513.68%
net current asset value
8.30M
-
3.44M
58.61%
-9.60M
379.53%
35.57M
470.36%
net debt to ebitda
0.89
-
-0.72
180.73%
4.13
674.43%
net income per share
-0.74
-
-5.67
668.28%
-0.79
86.13%
operating cash flow per share
-0.59
-
-2.79
372.82%
-1.10
60.61%
payables turnover
receivables turnover
research and ddevelopement to revenue
0.92
-
return on tangible assets
-1.02
-
-1.75
72.02%
-0.19
88.93%
revenue per share
0.59
-
roe
-1.34
-
1.75
230.83%
-0.22
112.82%
roic
-1.33
-
-2.57
93.31%
-0.20
92.10%
sales general and administrative to revenue
1.31
-
shareholders equity per share
0.55
-
-3.24
687.25%
3.51
208.20%
stock based compensation to revenue
0.15
-
tangible asset value
8.30M
-
3.64M
56.11%
-8.39M
330.36%
35.64M
524.56%
tangible book value per share
0.55
-
-3.24
687.25%
3.51
208.20%
working capital
8.30M
-
3.44M
58.61%
3.36M
2.17%
36.14M
975.30%

All numbers in USD (except ratios and percentages)